Analyst Price Target is $14.83
▲ +95.43% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is $14.83, with a high forecast of $19.00 and a low forecast of $11.00. The average price target represents a 95.43% upside from the last price of $7.59.
Current Consensus is
The current consensus among 5 polled investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.